Providing Access to the Visual Environment

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by Vanderbilt University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Tennessee Department of Education
Information provided by:
Vanderbilt University
ClinicalTrials.gov Identifier:
NCT00341744
First received: June 20, 2006
Last updated: July 12, 2010
Last verified: July 2010
  Purpose

Providing Access to the Visual Environment is a pediatric low vision grant which has the ability to provide comprehensive, interdisciplinary low vision rehabilitation services to every child in Tennessee with a vision impairment. Children, ages 3-21, with best-corrected vision of 20/50 or worse in the better seeing eye are prescribed optical devices to improve their visual functioning and trained to use the devices.


Condition
Vision Impairment

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Providing Access to the Visual Environment

Further study details as provided by Vanderbilt University:

Estimated Enrollment: 795
Study Start Date: July 2001
Estimated Study Completion Date: December 2010
Detailed Description:

Subjects are enrolled each school year based on referrals from school systems in Tennessee, ophthalmologists, and optometrists. A total of 90 new students are enrolled each year. Students are provided a comprehensive low vision rehabilitation evaluation by a low vision optometrist and prescribed optical devices to improve distance appreciation, near reading, and other tasks based on individual needs. Students are then trained to use the devices efficiently by master's level teachers of the visually impaired. The teachers travel to the students environment (school/home/work) for the training.

Variables such as ocular disease, age, visual acuity, visual improvement with optical devices, type of optical device, and reading speed are defined for each student. Providing Access to the Visual Environment also provides...

  Eligibility

Ages Eligible for Study:   3 Years to 21 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Children age 3 to 21 years of age, enrolled in a TN school, with visual impairment

Criteria

Inclusion Criteria:

Children age 3 to 21 years of age Enrollment in a school in Tennessee (private or public)

- Children that are eligible for services due to visual impairment Low vision

Exclusion Criteria:

  • Children who do not have the potential to become readers or use their vision for reading
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00341744

Contacts
Contact: Jeffrey Sonsino, O.D. 615-936-2020 jeffrey.sonsino@vanderbilt.edu
Contact: Sandy A Owings, COA, CCRP 615-936-3465 sandy.owings@vanderbilt.edu

Locations
United States, Tennessee
Vanderbilt Eye Institute Recruiting
Nashville, Tennessee, United States, 37232-8808
Contact: Sandy A Owings, COA, CCRP    615-936-3465    sandy.owings@vanderbilt.edu   
Contact: Jeffrey Sonsino, O.D.    615-936-2020    jeffrey.sonsino@vanderbilt.edu   
Principal Investigator: Jeffrey Sonsino, O.D         
Sponsors and Collaborators
Vanderbilt University
Tennessee Department of Education
Investigators
Principal Investigator: Sonsino Jeffrey, O.D. Vanderbilt Eye Institute
  More Information

No publications provided

Responsible Party: Jeffrey Sonsino, OD,PI, Vanderbit University Medical Center
ClinicalTrials.gov Identifier: NCT00341744     History of Changes
Other Study ID Numbers: 7633
Study First Received: June 20, 2006
Last Updated: July 12, 2010
Health Authority: United States: Food and Drug Administration

Keywords provided by Vanderbilt University:
Vision
Aids

ClinicalTrials.gov processed this record on August 20, 2014